Australian researchers believe cannabidiol (CBD) may help alleviate cognitive impairment in patients with schizophrenia, a serious condition that can profoundly affect those suffering from...
Australia's Botanix (ASX:BOT) has partnered with the University of Queensland’s (UQ) Institute for Molecular Bioscience (IMB) to accelerate the company's BTX 1801 toward clinical...